Combination therapy of poseltinib for preventing or treating lymphoma

TW202639132APending Publication Date: 2026-10-01NOBLE PHARMACEUTICALS +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146458
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-03
Filing Date
2025-11-27
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078592_001
    Figure TWG2TA001078592_001
  • Figure TWG2TA001078592_002
    Figure TWG2TA001078592_002
  • Figure TWG2TA001078592_003
    Figure TWG2TA001078592_003
Patent Text Reader

Abstract

The present invention relates to a therapeutic regimen for the prevention or treatment of lymphoma comprising poseltinib for co-administration with golcadomide. In particular, the present invention achieves a synergistic effect in the prevention or treatment of diffuse large B-cell lymphoma (DLBCL) and primary central nervous system lymphoma (PCNSL) by co-administering poseltinib and golcadomide.
Need to check novelty before this filing date? Find Prior Art